FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808562116> ?p ?o ?g. }

• W2808562116 abstract "Arsenic trioxide (As2O3), a drug that has been used in China for approximately two thousand years, induces cell death in a variety of cancer cell types, including neuroblastoma (NB). The tyrosine kinase receptor (Trk) family comprises three members, namely TrkA, TrkB and TrkC. Various studies have confirmed that TrkA and TrkC expression is associated with a good prognosis in NB, while TrkB overexpression can lead to tumor cell growth and invasive metastasis. Previous studies have shown that As2O3 can inhibit the growth and proliferation of a human NB cell line and can also affect the N-Myc mRNA expression. It remains unclear whether As2O3 regulates Trks for the purposes of treating NB.The aim of the present study was to investigate the effect of As2O3 on Trk expression in NB cell lines and its potential therapeutic efficacy. SK-N-SH cells were grown with increasing doses of As2O3 at different time points. We cultured SK-N-SH cells, which were treated with increasing doses of As2O3 at different time points. Trk expression in the NB samples was quantified by immunohistochemistry, and the cell cycle was analyzed by flow cytometry. TrkA, TrkB and TrkC mRNA expression was evaluated by real-time PCR analysis.Immunohistochemical and real-time PCR analyses indicated that TrkA and TrkC were over-expressed in NB, and specifically during stages 1, 2 and 4S of the disease progression. TrkB expression was increased in stage 3 and 4 NB. As2O3 significantly arrested SK-N-SH cells in the G2/M phase. In addition, TrkA, TrkB and TrkC expression levels were significantly upregulated by higher concentrations of As2O3 treatment, notably in the 48-h treatment period. Our findings suggested that to achieve the maximum effect and appropriate regulation of Trk expression in NB stages 1, 2 and 4S, As2O3 treatment should be at relatively higher concentrations for longer delivery times;however, for NB stages 3 and 4, an appropriate concentration and infusion time for As2O3 must be carefully determined.The present findings suggested that As2O3 induced Trk expression in SK-N-SH cells to varying degrees and may be a promising adjuvant to current treatments for NB due to its apoptotic effects." @default.
• W2808562116 created "2018-06-21" @default.
• W2808562116 creator A5007672078 @default.
• W2808562116 creator A5008599644 @default.
• W2808562116 creator A5017360203 @default.
• W2808562116 creator A5022089337 @default.
• W2808562116 creator A5042515616 @default.
• W2808562116 creator A5059447916 @default.
• W2808562116 creator A5065158972 @default.
• W2808562116 date "2018-06-13" @default.
• W2808562116 modified "2023-10-13" @default.
• W2808562116 title "Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells" @default.
• W2808562116 cites W1488909776 @default.
• W2808562116 cites W1567431652 @default.
• W2808562116 cites W1869911437 @default.
• W2808562116 cites W1937005742 @default.
• W2808562116 cites W1969149009 @default.
• W2808562116 cites W1970206239 @default.
• W2808562116 cites W1974248844 @default.
• W2808562116 cites W1984058198 @default.
• W2808562116 cites W1987690978 @default.
• W2808562116 cites W1991730900 @default.
• W2808562116 cites W1998641915 @default.
• W2808562116 cites W2004588801 @default.
• W2808562116 cites W2006025476 @default.
• W2808562116 cites W2009604927 @default.
• W2808562116 cites W2022775759 @default.
• W2808562116 cites W2023396081 @default.
• W2808562116 cites W2023499824 @default.
• W2808562116 cites W2043415995 @default.
• W2808562116 cites W2049523663 @default.
• W2808562116 cites W2065756782 @default.
• W2808562116 cites W2070564143 @default.
• W2808562116 cites W2072484647 @default.
• W2808562116 cites W2084735086 @default.
• W2808562116 cites W2084992833 @default.
• W2808562116 cites W2086343926 @default.
• W2808562116 cites W2089385034 @default.
• W2808562116 cites W2096398040 @default.
• W2808562116 cites W2098752829 @default.
• W2808562116 cites W2099603517 @default.
• W2808562116 cites W2100835711 @default.
• W2808562116 cites W2104320396 @default.
• W2808562116 cites W2106049320 @default.
• W2808562116 cites W2117000594 @default.
• W2808562116 cites W2135082263 @default.
• W2808562116 cites W2140493919 @default.
• W2808562116 cites W2144876051 @default.
• W2808562116 cites W2158958901 @default.
• W2808562116 cites W2159714394 @default.
• W2808562116 cites W2167769671 @default.
• W2808562116 cites W2169013957 @default.
• W2808562116 cites W2176479197 @default.
• W2808562116 cites W2178678422 @default.
• W2808562116 cites W2188671718 @default.
• W2808562116 cites W2226728925 @default.
• W2808562116 cites W2272786434 @default.
• W2808562116 cites W2411244835 @default.
• W2808562116 cites W2493492294 @default.
• W2808562116 cites W2508359700 @default.
• W2808562116 cites W2548624119 @default.
• W2808562116 cites W2609910740 @default.
• W2808562116 cites W2767969168 @default.
• W2808562116 cites W4240368944 @default.
• W2808562116 doi "https://doi.org/10.1186/s40659-018-0167-6" @default.
• W2808562116 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5998579" @default.
• W2808562116 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29898774" @default.
• W2808562116 hasPublicationYear "2018" @default.
• W2808562116 type Work @default.
• W2808562116 sameAs 2808562116 @default.
• W2808562116 citedByCount "11" @default.
• W2808562116 countsByYear W28085621162019 @default.
• W2808562116 countsByYear W28085621162020 @default.
• W2808562116 countsByYear W28085621162021 @default.
• W2808562116 countsByYear W28085621162022 @default.
• W2808562116 countsByYear W28085621162023 @default.
• W2808562116 crossrefType "journal-article" @default.
• W2808562116 hasAuthorship W2808562116A5007672078 @default.
• W2808562116 hasAuthorship W2808562116A5008599644 @default.
• W2808562116 hasAuthorship W2808562116A5017360203 @default.
• W2808562116 hasAuthorship W2808562116A5022089337 @default.
• W2808562116 hasAuthorship W2808562116A5042515616 @default.
• W2808562116 hasAuthorship W2808562116A5059447916 @default.
• W2808562116 hasAuthorship W2808562116A5065158972 @default.
• W2808562116 hasBestOaLocation W28085621161 @default.
• W2808562116 hasConcept C105696609 @default.
• W2808562116 hasConcept C134139212 @default.
• W2808562116 hasConcept C153911025 @default.
• W2808562116 hasConcept C160539049 @default.
• W2808562116 hasConcept C170493617 @default.
• W2808562116 hasConcept C171034665 @default.
• W2808562116 hasConcept C180361614 @default.
• W2808562116 hasConcept C190283241 @default.
• W2808562116 hasConcept C2775960820 @default.
• W2808562116 hasConcept C2776715637 @default.
• W2808562116 hasConcept C2780386689 @default.
• W2808562116 hasConcept C29537977 @default.
• W2808562116 hasConcept C42362537 @default.
• W2808562116 hasConcept C502942594 @default.
• W2808562116 hasConcept C54355233 @default.

• next